Ben R Taylor
Chief Financial Officer · 4 filings · Latest: Apr 6, 2026
RECURSION PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXRX | Ben R Taylor | Chief Financial Officer | Mar 17, 2026 | Sale | $3.39 | 7,956 | $27.0K | 1,180,318 | |
RXRX | Taylor Ben R | — | Mar 17, 2026 | Proposed Sale | $3.39 | 7,956 | $27.0K | — | |
RXRX | Ben R Taylor | Chief Financial Officer | Feb 18, 2026 | Sale | $3.08 | 13,426 | $41.4K | 1,195,349 | |
RXRX | Taylor Ben R | — | Feb 18, 2026 | Proposed Sale | $3.08 | 13,426 | $41.4K | — | |
RXRX | Taylor Ben R | — | Dec 29, 2025 | Proposed Sale | $4.18 | 21,383 | $89.4K | — |